8.04
price up icon1.13%   0.09
after-market Dopo l'orario di chiusura: 8.04
loading

Kamada Ltd Borsa (KMDA) Ultime notizie

pulisher
Jan 08, 2026

Can Kamada Ltd. stock attract ESG capital inflowsMarket Performance Recap & Low Drawdown Momentum Trade Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Benchmark reiterates Buy rating on Kamada stock, maintains $15 target By Investing.com - Investing.com Nigeria

Jan 08, 2026
pulisher
Jan 08, 2026

Kamada 2025/2026 Outlook: Evaluating Revenue Growth And Product Drivers (NASDAQ:KMDA) - Seeking Alpha

Jan 08, 2026
pulisher
Jan 07, 2026

Kamada (KMDA) Projects Strong Revenue and EBITDA Growth by 2026 - GuruFocus

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada shares climb after upbeat 2026 outlook points to double-digit growth - MSN

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada stock rises after issuing 2026 guidance showing double-digit growth - Investing.com Canada

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada forecasts 13% revenue growth in 2026, issues guidance By Investing.com - Investing.com Nigeria

Jan 07, 2026
pulisher
Jan 07, 2026

Kamada Provides 2026 Annual Guidance of $200$205 Million - GlobeNewswire

Jan 07, 2026
pulisher
Jan 06, 2026

Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Jan 06, 2026
pulisher
Jan 02, 2026

Kamada Ltd. (KMDA) Stock Analysis: Unearthing an 84% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Jan 02, 2026
pulisher
Jan 01, 2026

Leasing LimitedFundamental Strength Indicators & Free Exceptional ROI Methods - bollywoodhelpline.com

Jan 01, 2026
pulisher
Dec 31, 2025

Kamada stock rises after issuing 2026 guidance showing double-digit growth By Investing.com - Investing.com South Africa

Dec 31, 2025
pulisher
Dec 28, 2025

Kamada Ltd. (NASDAQ:KMDA) Short Interest Update - MarketBeat

Dec 28, 2025
pulisher
Dec 23, 2025

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat

Dec 23, 2025
pulisher
Dec 23, 2025

Kamada (NASDAQ:KMDA) Shares Pass Above 50-Day Moving Average – Time to Sell? - Defense World

Dec 23, 2025
pulisher
Dec 23, 2025

Kamada (KMDA) price target decreased by 11.86% to 13.26 - MSN

Dec 23, 2025
pulisher
Dec 22, 2025

Kamada (KMDA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 22, 2025
pulisher
Dec 21, 2025

Kamada Ltd.(NasdaqGS: KMDA) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 20, 2025

Is Kamada Ltd. stock affected by interest rate hikesInsider Selling & Long-Term Growth Plans - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Will Kamada Ltd. stock see insider buyingWeekly Trend Recap & Precise Entry and Exit Recommendations - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Is Kamada Ltd. stock positioned well for digital economyLayoff News & Fast Exit and Entry Strategy Plans - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Can Kamada Ltd. stock resist sector downturns2025 Top Gainers & Expert-Curated Trade Recommendations - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Kamada announces $10M-$14M extension of Canadian supply tender - TipRanks

Dec 19, 2025
pulisher
Dec 18, 2025

Can Kamada Ltd. stock rebound after recent weaknessIndex Update & Consistent Return Strategy Ideas - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Breakout Watch: Is Kamada Ltd. stock positioned well for digital economyJuly 2025 News Drivers & Growth Focused Entry Point Reports - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada secures $10-14 million Canadian supply tender extension By Investing.com - Investing.com Nigeria

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada Ltd. Announces $10 Million to $14 Million Extension of Canadian Supply Tender - marketscreener.com

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada Receives Two-Year Supply Extension From Canadian Blood Services for Plasma-Derived Products - marketscreener.com

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada Wins $10–$14 Million Extension of Canadian Plasma-Product Tender - TipRanks

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada secures $10-14 million Canadian supply tender extension - Investing.com

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada (KMDA) announces $10–$14 million extension of Canadian tender - Stock Titan

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender - GlobeNewswire

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada Initiates Clinical Trial for CYTOGAM in Kidney Transplantation - MSN

Dec 18, 2025
pulisher
Dec 18, 2025

Kamada shares drop as company halts Phase 3 study of inhaled AAT therapy - MSN

Dec 18, 2025
pulisher
Dec 15, 2025

Breakout Zone: How geopolitical tensions affect Kamada Ltd stock2025 Earnings Surprises & Consistent Return Investment Signals - moha.gov.vn

Dec 15, 2025
pulisher
Dec 13, 2025

Precision Trading with Kamada Ltd. (KMDA) Risk Zones - Stock Traders Daily

Dec 13, 2025
pulisher
Dec 13, 2025

Kamada (NASDAQ:KMDA) Stock Rating Upgraded by Wall Street Zen - Defense World

Dec 13, 2025
pulisher
Dec 12, 2025

FY2025 Earnings Forecast for Kamada Issued By HC Wainwright - Defense World

Dec 12, 2025
pulisher
Dec 11, 2025

What is HC Wainwright's Forecast for Kamada FY2025 Earnings? - MarketBeat

Dec 11, 2025
pulisher
Dec 11, 2025

Sidoti Csr Comments on Kamada’s Q1 Earnings (NASDAQ:KMDA) - Defense World

Dec 11, 2025
pulisher
Dec 11, 2025

HC Wainwright Has Bearish Outlook for Kamada FY2026 Earnings - Defense World

Dec 11, 2025
pulisher
Dec 10, 2025

Kamada Ltd. Shareholders Approve Key Resolutions at Annual Meeting - TipRanks

Dec 10, 2025
pulisher
Dec 10, 2025

Sidoti Csr Predicts Kamada's Q1 Earnings (NASDAQ:KMDA) - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus - Investing.com Nigeria

Dec 09, 2025
pulisher
Dec 09, 2025

H.C. Wainwright raises Kamada stock price target to $13 on strategic refocus By Investing.com - Investing.com South Africa

Dec 09, 2025
pulisher
Dec 08, 2025

Why Is Kamada Stock Trading lower todayKamada (NASDAQ:KMDA) - Benzinga

Dec 08, 2025
pulisher
Dec 08, 2025

Kamada to Discontinue Phase 3 Trial of Inhaled AAT: Shares Fall - marketscreener.com

Dec 08, 2025
pulisher
Dec 08, 2025

Kamada discontinues Phase 3 inhaled AAT clinical trial - TipRanks

Dec 08, 2025
drug_manufacturers_specialty_generic RDY
$13.40
price up icon 0.37%
$23.47
price up icon 0.99%
$135.79
price up icon 0.16%
$12.76
price up icon 1.27%
$483.23
price down icon 1.55%
drug_manufacturers_specialty_generic RGC
$45.79
price up icon 10.55%
Capitalizzazione:     |  Volume (24 ore):